Understanding how dynamin affects pancreatic beta-cell function in diabetes
Dynamin function in pancreatic beta-cell autophagy
This study is looking at how a protein called dynamin helps keep insulin-producing cells in the pancreas healthy, which could lead to new ways to treat diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10885088 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called dynamin in the process of autophagy within pancreatic beta cells, which are crucial for insulin production. By exploring how dynamin influences the health and function of these cells, the research aims to uncover new therapeutic targets for diabetes treatment. The approach includes advanced techniques like live-cell imaging to observe the behavior of dynamin in real-time. The ultimate goal is to better understand the mechanisms that protect beta cells from damage and decline, which is a significant issue in diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with adult-onset diabetes mellitus who are experiencing a decline in pancreatic beta cell function.
Not a fit: Patients with type 1 diabetes or those whose diabetes is not related to pancreatic beta cell dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent the decline of pancreatic beta cells, potentially reversing diabetes in patients.
How similar studies have performed: Previous research has shown that targeting autophagy can reverse diabetes in animal models, indicating a promising avenue for further exploration.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Lou, Xuelin — Medical College of Wisconsin
- Study coordinator: Lou, Xuelin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.